Item Size & Content:
Expand the production scale of Haytitier magnesium aluminate tablet.
Construction Conditions & Market Prospect:
Haytitier magnesium aluminate tablet is a kind of national-level new medicine, and the class-A non-prescribed medicine. With its quick-acting, effective, safe and also non-poisonous functions, it has been widely applied to gastralgia, peptic ulcer and other tummy bugs. Depending on its remarkable curative effect, it’s regarded as the renewed anti-aluminic acid pharmaceutics. The product has shown its spacious market prospect.
Competitive Advantage & Current Progress:
The product has been put into markets in small lots and gained fine reflections in Hubei province and neighboring areas.
Construction Site & Period:
The construction site is in Huangshi Development Zone.
The construction period is 1 year.
Economic Evaluation  :
The annual sales revenue is RMB 50million Yuan;
The profit payments and tax turnover is RMB 15million Yuan;
The investment payback period is 4 years.
Investment & Its Compositions  :
Total investment is RMB 30million Yuan, with RMB 10milllion Yuan invested in fixed assets and RMB 20million Yuan in circulating capital. RMB 20million Yuan is planned to introduce from abroad.
Cooperation Form:
Joint venture; Cooperation
Brief of Item Owner :
Meisheng Pharmaceutical Company, Hubei Mailyard(Group), is an integrated pharmaceutical enterprise, with a group of talented engineers and technicians. Its workshops for manufacturing tablet and injection respectively, have already passed the GMP Recognition, and possessed the production capabilities of more than eighty kinds.

Contact 
 Unit: Investment Promotion Section , Huangshi Municipal Bureau of Investment Promotion
Person to contact:  Wu Chaoyang;  Zheng Fen
Tel:  0086-714-6359875
Fax:  0086-714-6368386
E-mail: hbhstz@sina.com